<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CETIRIZINE</span><br/>(ce-tir'i-zeen)<br/><span class="topboxtradename">Reactine <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Zyrtec<br/></span><b>Classifications:</b> <span class="classification">antihistamine</span>; <span class="classification">h<sub>1</sub>-receptor antagonist</span>; <span class="classification">non-sedating</span><br/><b>Prototype: </b>Loratidine<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg, 10 mg tablets; 5 mg, 10 mg chewable tablets; 5 mg/5 mL syrup</p>
<h1><a name="action">Actions</a></h1>
<p>Cetirizine is a potent H<sub>1</sub>-receptor antagonist and thus an antihistamine without significant anticholinergic or CNS activity. Low lipophilicity combined
         with its H<sub>1</sub>-receptor selectivity probably accounts for its relative lack of anticholinergic and sedative properties.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effectively treats allergic rhinitis, and chronic urticaria by eliminating or reducing the local and systemic effects of histamine
         release.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to H<sub>1</sub>-receptor antihistamines; lactation, children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Moderate to severe renal impairment, pregnancy (category B), children.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Allergic Rhinitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 510 mg once/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>25 y:</i> 2.5 mg q.d. (max: 5 mg/d); <img src="../images/special/greaterorequal.gif"/><i>6 y:</i> 510 mg q.d.<br/><br/><span class="indicationtitle">Chronic Urticaria</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 10 mg q.d. or b.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Consult physician about dosage if significant adverse effects appear. As elimination half-life is prolonged in the older adult,
            dosage adjustments may be warranted.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> GI:</span> Constipation, diarrhea, dry mouth. <span class="typehead">CNS:</span>
<span class="speceff-common">Drowsiness, sedation, headache,</span> depression. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Theophylline</b> may decrease cetirizine clearance leading to toxicity. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 1 h. <span class="typehead"> Distribution:</span> 93% protein bound; minimal CNS concentrations. <span class="typehead">Metabolism:</span> minimal. <span class="typehead">Elimination:</span> 60% excreted unchanged in urine within 24 h, 5% excreted in feces. <span class="typehead">Half-Life:</span> 7.4 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for drug interactions. As the drug is highly protein bound, the potential for interactions with other protein-bound
            drugs exists.
         </li>
<li>Monitor for sedation, especially the older adult.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not use in combination with OTC antihistamines.</li>
<li>Do not engage in driving or other hazardous activities, before experiencing your responses to the drug.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>